首页 | 本学科首页   官方微博 | 高级检索  
     


Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors
Authors:Carlotta Granchi  Isabella Caligiuri  Eleonora Bertelli  Giulio Poli  Flavio Rizzolio  Marco Macchia
Affiliation:1. Department of Pharmacy, University of Pisa, Pisa, Italy;2. Unit of Pathology, Department of Molecular Biology and Translational Research, National Cancer Institute and Center for Molecular Biomedicine, Aviano, Pordenone, Italy;3. Department of Molecular Sciences and Nanosystems, Ca’ Foscari Università di Venezia, Venezia-Mestre, Italy
Abstract:Monoacylglycerol lipase is a serine hydrolase that plays a major role in the degradation of the endocannabinoid neurotransmitter 2-arachidonoylglycerol. A wide number of MAGL inhibitors are reported in literature; however, many of them are characterised by an irreversible mechanism of action and this behavior determines an unwanted chronic MAGL inactivation, which acquires a functional antagonism of the endocannabinoid system. The possible use of reversible MAGL inhibitors has only recently been explored, due to the lack of known compounds possessing efficient reversible inhibitory activities. In this work, we report a new series of terphenyl-2-methyloxazol-5(4H)-one derivatives characterised by a reversible MAGL-inhibition mechanism. Among them, compound 20b showed to be a potent MAGL reversible inhibitor (IC50?=?348?nM) with a good MAGL/FAAH selectivity. Furthermore, this compound showed antiproliferative activities against two different cancer cell lines that overexpress MAGL.
Keywords:Monoacylglycerol lipase inhibitors  endocannabinoids  docking  molecular dynamic simulations
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号